- Home
- SWIN vs PULM Comparison
SWIN vs PULM Comparison
Compare SWIN & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- PULM
- Stock Information
- Founded
- SWIN 2017
- PULM 2003
- Country
- SWIN Hong Kong
- PULM United States
- Employees
- SWIN N/A
- PULM N/A
- Industry
- SWIN
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- SWIN
- PULM Health Care
- Exchange
- SWIN Nasdaq
- PULM Nasdaq
- Market Cap
- SWIN 214.1M
- PULM 20.5M
- IPO Year
- SWIN 2023
- PULM N/A
- Fundamental
- Price
- SWIN $3.93
- PULM $5.57
- Analyst Decision
- SWIN
- PULM
- Analyst Count
- SWIN 0
- PULM 0
- Target Price
- SWIN N/A
- PULM N/A
- AVG Volume (30 Days)
- SWIN 208.1K
- PULM 10.9K
- Earning Date
- SWIN 08-21-2025
- PULM 08-12-2025
- Dividend Yield
- SWIN N/A
- PULM N/A
- EPS Growth
- SWIN N/A
- PULM N/A
- EPS
- SWIN N/A
- PULM N/A
- Revenue
- SWIN $3,316,000.00
- PULM $1,921,000.00
- Revenue This Year
- SWIN $29.79
- PULM N/A
- Revenue Next Year
- SWIN $54.60
- PULM $134.88
- P/E Ratio
- SWIN N/A
- PULM N/A
- Revenue Growth
- SWIN N/A
- PULM N/A
- 52 Week Low
- SWIN $1.16
- PULM $1.78
- 52 Week High
- SWIN $4.40
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- SWIN 62.05
- PULM 36.25
- Support Level
- SWIN $3.70
- PULM $5.20
- Resistance Level
- SWIN $3.99
- PULM $6.15
- Average True Range (ATR)
- SWIN 0.35
- PULM 0.30
- MACD
- SWIN -0.03
- PULM -0.05
- Stochastic Oscillator
- SWIN 93.02
- PULM 22.70
About SWIN Solowin Holdings
Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).